If ANY of that were accurate, BIEL would have rocked on FDA approval and stayed there - hitting a half cent or even more, and showing some holding power.
Unfortunately, BIEL performed as one would expect with billions of shareas available and zero interest from new investors: flippers churned and longs dumped, piggy-backing off the abysmal share structure to ultimately tank the price.
FACT: if share structure didn't matter, BIEL wouldn't be at .0005 today.
Actually the concept is extremely simple to grasp, what you fail to grasp is that any company with 22B shares in issue is never going to be worth more that a couple of pennies, if that. When you can spend $1000 and get 2M shares you are running with the bottom feeders. I have been here since the WSJ article too many years ago for me to remember and I didn't get out when I should have so I hung on hoping some day it may get to a few pennies so I could recover something. I hate reverse splits as they are killers but until they get the shares in issue into the 100's of million this is garbage. Their product may be great but share structure sucks.
News 
Market Data 
Discover 
AI
